Introduction: Pancreatitis is an inflammatory process in which pancreatic enzymes autodigest the gland. The gland heals without any impairment of function or any morphologic changes. Management depends largely on severity. Medical treatment of mild acute pancreatitis is relatively straightforward. Treatment of severe acute pancreatitis involves intensive care; the goals of medical management are to provide aggressive supportive care, to decrease inflammation, to limit infection or superinfection, and to identify and treat complications as appropriate. Worldwide, the incidence of acute pancreatitis ranges between 5 and 80 per 100,0001, so the disease is rather common, necessitating the means to differentiate between mild and severe forms, due to both health related end economic reasons
Goals: To determine the possible applications of C reactive protein (CRP) and Bisap score in determining the severity of accute pancreatitis.
Means and Methods: A retrospective analysis of 130 case histories of patiens, treated in Vilnius Univeristy Santaros clinics, from year 2014 to 2015, with a diagnosed and confirmed accute pancreatitis.The patien were grouped according to Atlanta2 classification into 3 groups of severity.The formed database was analysed, comparing the correlation cooficient and median scores of CRP in comparison to Ranson scale.
Results: Ranson score was significantly higher in Atlanta 3 group, compared to Atlanta 1 and 2 $(1,32 \pm 1,18 \text{ vs } 1,53\pm 1,08 \text{ vs } 3\pm 1,53)$.A weak/ intermediate correlation between CRP and severity of acute pancreatitis was determined.Correlation coefficient of Ranson score was 0,619, compared to CRP's correlation coefficient of 0,373
Conclusions: Ranson score proved unable to distinguish between Atlanta 1 and 2 groups, but proved to be valuable in identifying Atlanta 3 severity group. CRP showed to weakly correlate with the grade of severity of acute pancreatitis, so although it might provide some usefull information on first presentation of disease, its value is rather limited.